SOPHiA GENETICS SA (SOPH) Tops Q4 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. GOOGL
9. RTX
10. S

Go back to SOPHiA GENETICS SA (SOPH) Tops Q4 EPS by 17c

SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results

March 7, 2023 7:00 AM EST

Fourth Quarter Revenue Growth Accelerates; Operating Losses Notably Moderate

BOSTON & LAUSANNE, Switzerland--(BUSINESS WIRE)-- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced financial results for its fourth quarter and full fiscal year ended December 31, 2022.

Recent Highlights

Revenue for the full-year 2022 was $47.6 million, representing year-over-year growth of 18% on a reported basis. 2022 constant currency revenue growth excluding COVID-19-related revenues was 39% Revenue was $13.4 million for the fourth quarter, representing a 22% increase on a reported basis over the corresponding... More